Cargando…
Morphea associated with primary biliary cirrhosis and Waldenstrom macroglobulinemia: Response to rituximab
Autores principales: | Traboulsi, Danya, Kaminska, Elzbieta A., Barr, Susan G., Hunter, Charlene, Mydlarski, P. Regine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141651/ https://www.ncbi.nlm.nih.gov/pubmed/30246126 http://dx.doi.org/10.1016/j.jdcr.2018.04.016 |
Ejemplares similares
-
Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015) -
Genomic landscape of Waldenström's macroglobulinemia
por: Treon, Steven P., et al.
Publicado: (2019) -
Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
por: Xu, XiaoWei, et al.
Publicado: (2013) -
A case of acquired angioedema associated with Waldenstrom’s macroglobulinemia treated with rituximab
por: Rizk, Caroline, et al.
Publicado: (2014) -
Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013)